Table 2 Primary outcome and nutrition outcomes in the infants included in the mITT analysis.
Clinical outcomes | n | BC group | n | CF group | Estimate [95% CIs] | p |
|---|---|---|---|---|---|---|
FI (binary), n (%) | 74 | 24 (32) | 72 | 21 (29) | 1.2 [0.6, 2.4]a | 0.66 |
FI (GA < 30 wks), n (%) | 44 | 19 (43) | 34 | 13 (37) | 1.4 [0.5, 3.4]a | 0.52 |
FI (GA ≥ 30 wks), n (%) | 30 | 5 (17) | 37 | 8 (22) | 0.8 [0.2, 3.1]a | 0.75 |
FI (site A), n (%) | 66 | 22 (33) | 65 | 20 (31) | 1.1 [0.5, 2.4]a | 0.77 |
FI (time-to-event) | 74 | 24 | 72 | 21 | 1.2 [0.6, 2.1]b | 0.61 |
TEF120, d | 74 | 21 ± 9 | 72 | 20 ± 10 | 0.13 [−0.03, 0.28]c | 0.11 |
TEF150 | 71/74 | 28 ± 12 | 68/71 | 26 ± 12 | 2 [−1, 5]b | 0.19 |
Days on PN, d | 74 | 18.6 ± 9.0 | 72 | 19.1 ± 12.2 | −0.01 [−0.20, 0.19]c | 0.96 |
Enteral nutrition volume during intervention, mL/kg WT/d | ||||||
Start | 74 | 109 ± 20 | 72 | 112 ± 21 | −3 [−10, 3] a | 0.71 |
Day 7 | 74 | 140 ± 23 | 71 | 141 ± 23 | −1 [−8, 7]c | 0.86 |
Day 14 | 73 | 151 ± 18 | 67 | 152 ± 16 | −0.6 [−6, 5]c | 0.84 |
End | 52 | 154 ± 16 | 57 | 152 ± 18 | 1.3 [−4, 8]c | 0.67 |
Protein from the fortifier, g/100 mL feed, median (min-max) | ||||||
Day 7 | 74 | 1.4 [0, 2] | 70 | 1.4 [0, 1.4] | 0.9 [−0.8, 0.6]c | 0.78 |
Day 14 | 73 | 1.4 [0, 2] | 68 | 1.4 [0, 1.4] | 1.4 [−0.4, 1.1]c | 0.38 |
End of intervention | 52 | 1.4 [0, 2.5] | 58 | 1.4 [0, 1.4] | 2.0 [−0.1, 1.5]c | 0.07 |
Protein from enteral nutrition, g/kg WT/d | ||||||
Day 7 | 74 | 3.7 ± 1.0 | 70 | 3.6 ± 1.1 | 0.1 [−0.3, 0.4]c | 0.98 |
Day 14 | 73 | 4.2 ± 0.9 | 68 | 3.9 ± 1.2 | 0.31 [−0.04, 0.65]c | 0.08 |
Infants needing fortification at the end of intervention, n (%) | 74 | 65 (89%) | 72 | 68 (94%) | 0.5 [0.1, 1.7]a | 0.24 |
Infants needing fortification at discharge, n (%) | 74 | 60 (82%) | 72 | 58 (82%) | 1.1 [0.4, 2.5]a | 0.88 |
MOM only at the end of intervention, n (%) | 74 | 62 (84%) | 72 | 60 (83%) | 1.0 [0.4, 2.5]a | 0.94 |
Infants on breastfeeding at discharge, n (%) | 74 | 61 (82%) | 72 | 62 (86%) | 0.8 [0.3, 1.9]a | 0.55 |